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The purpose of this study was to investigate the presence of the anaerobic intestinal spirochetes Brachyspira
aalborgi and Brachyspira pilosicoli in the feces of captive nonhuman primates (n  35) from 19 species housed
at the Zoological Gardens, Perth, Western Australia. Both spirochete species are known to infect human
beings. DNA was extracted from freshly collected feces with a commercially available QIAamp DNA stool
minikit and subjected to PCR protocols amplifying portions of the 16S rRNA genes of the two spirochete
species. The feces were also subjected to selective culture for the spirochetes. Subsequently, feces from 62 other
captive animals or birds representing 39 species at the zoo were examined by PCR to determine whether they
were reservoirs of infection. Six fecal samples from individuals from four primate species (two vervet monkeys,
two Tonkean macaques, one Japanese macaque, and one hamadryas baboon) tested positive in the B. aalborgi
PCR. B. aalborgi was not detected by PCR in any of the other animal or bird species tested, and B. pilosicoli was
not detected in the primates or any of the other animals or birds. B. aalborgi was isolated from both
PCR-positive vervet monkeys. This is the ﬁrst time that B. aalborgi has been isolated from nonhuman primates
and the ﬁrst time that it has been isolated from the feces of any species.
The term intestinal spirochetosis (IS) was originally used to
describe a condition in which a dense fringe of spirochetal
bacteria was observed attached by one cell end to the colorec-
tal epithelium of humans, forming a “false brush border” (5).
Since that ﬁrst description, the clinical signiﬁcance of this col-
onization has been debated, but a number of studies have
linked the condition to symptoms including chronic diarrhea
and rectal bleeding (3, 5, 19). Clinical symptoms have some-
times improved following antimicrobial treatment that has re-
moved the spirochetes (6, 18). Two species of fastidious an-
aerobic spirochetes have been associated with IS: Brachyspira
aalborgi (7–9, 13) and Brachyspira pilosicoli (23–25). Fecal cul-
ture has been used to show that colonization with B. pilosicoli
is widespread among people living in developing countries (1,
25), but in developed countries it is common only in homosex-
ual males (23). The spirochete also colonizes many animal
species, including pigs and dogs, and birds (20, 24, 25). In
contrast, recent studies using PCR on DNA extracted from
colorectal biopsy specimens or direct in situ hybridization on
biopsy specimens have demonstrated that B. aalborgi is the
most common cause of IS among patients in Western coun-
tries, with B. pilosicoli only occasionally being detected (8, 10,
12–14). Both species of spirochete are slow-growing anaerobes
with specialized growth requirements, but B. aalborgi is even
more fastidious than B. pilosicoli. To date there have only been
three reports of B. aalborgi having been isolated, in all cases
directly from human colorectal biopsy specimens (7–9). B.
aalborgi has never been isolated from feces, although its pres-
ence has been detected in feces using PCR (15).
A spirochetal colonization of the large intestine which is
morphologically identical to human IS has been observed in a
number of nonhuman primate species, including colony-raised
rhesus monkeys (Macaca mulatta) (4, 21, 22), wild-caught
baboons (Papio spp.) (17), and wild-caught vervet monkeys
(Cercopithecus aethiops) (2). To date the only study which
attempted to identify such organisms was undertaken by Du-
hamel and colleagues, who observed spirochetes attached to
the colonic mucosa among a group of 10 colony-raised rhesus
monkeys and two crab-eating monkeys (Macaca fascicularis)
housed in a research institute (4). Using selective-culture tech-
niques, they isolated B. pilosicoli from ﬁve of the rhesus mon-
keys. They then applied PCR to DNA extracted from formalin-
ﬁxed colonic biopsy specimens and identiﬁed B. pilosicoli DNA
in two of these culture-positive monkeys. In addition, B. aal-
borgi DNA was detected in seven of the rhesus monkeys (in-
cluding two that were also positive for B. pilosicoli) and in both
crab-eating monkeys.
The aims of the present study were to determine whether
captive nonhuman primates in a public zoological collection
were colonized with intestinal spirochetes and to determine
which spirochete species might be involved. Other animal and
bird species in the collection were also tested for the presence
of B. aalborgi and B. pilosicoli to determine whether and to
what extent such captive species on the same site might be
infected. In view of the fastidious growth requirements of the
spirochetes, direct PCRs were conducted on DNA extracted
from feces. For comparative purposes, selective culture de-
signed to isolate B. aalborgi and B. pilosicoli was also under-
taken on the fecal samples from the nonhuman primates.
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Fecal samples. A total of 97 fresh fecal samples from 59 animal and bird
species were collected by zookeepers at the Zoological Gardens in Perth, West-
ern Australia. Thirty-ﬁve of the samples were from 19 nonhuman primate species
(Table 1), each species of which lived in a separate enclosure. The remaining
samples included 18 from 14 species of birds, 7 from 7 species of reptiles, and 37
from 18 species of marsupials and mammals. The animals were observed, and the
fecal samples were collected from the ﬂoors of the cages after they had been
deposited. A single sample was collected from each animal. The samples were
stored at 4°C and transported to Murdoch University for processing within 24 h
of collection.
Control spirochete strains and media. Control spirochete strains were ob-
tained from the collection held at the Reference Center for Intestinal Spiro-
chetes, Murdoch University. B. aalborgi 513A
T and B. pilosicoli P43/6/78
T were
revived from frozen stock and propagated anaerobically in an atmosphere of
94% H2 and 6% CO2 at 37°C on nonselective Trypticase soy agar (TSA) (BBL,
Cockeysville, Md.) containing 10% (vol/vol) deﬁbrinated ovine blood for up to 15
days for B. aalborgi. Viable cells were scraped from the agar and suspended in TE
buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) to a concentration of 10
11 cells
per ml.
PCRs. The PCRs used were based on those described for detection of the
spirochete species in human colorectal biopsy specimens and feces (13–15). The
target for B. aalborgi PCR ampliﬁcation was a 471-bp section of the 16S rRNA
gene equivalent to bp 172 to 675 of the 16S rRNA gene of Escherichia coli, while
for B. pilosicoli it was a 439-bp section of the 16S rRNA gene equivalent to bp 204
to 676 of the 16S rRNA gene of E. coli.
Throughout the study, standard procedures were followed to prevent possible
contamination of the PCRs. A biosafety cabinet was used for handling feces. For
pipetting, dedicated pipettes with ﬁltered tips were used. DNA extraction, PCR
setup, and ampliﬁcation were undertaken in three separate rooms. The ampli-
ﬁcation mixtures (25 l) contained 1 PCR buffer, 0.55 U of Tth Plus DNA
polymerase, 1.5 mM MgCl2, 5 nmol of each deoxynucleoside triphosphate (Am-
ersham Pharmacia Biotech AB, Uppsala, Sweden), and 12.5 pmol of each
primer. Thermocycling was as follows: denaturation for 4 min 30 s at 94°C,
followed by 33 cycles of denaturation at 94°C for 30 s, annealing at 46°C for B.
aalborgi or 51°C for B. pilosicoli, and primer extension at 72°C for 30 s and a ﬁnal
extension at 72°C for 5 min. The PCR products were subjected to electrophoresis
in 1.5% agarose gels in 1 TAE buffer (40 mM Tris-acetate, 1 mM EDTA) for
25 min at 110 V, stained by immersion for 10 min in ethidium bromide at a
concentration of 0.001 mg/ml in distilled water, and then viewed over UV light.
PCR sensitivities. The sensitivities of the PCRs were estimated by seeding
human feces previously shown to be negative for B. aalborgi and B. pilosicoli by
culture and PCR with known concentrations of B. aalborgi or B. pilosicoli cells.
A range of 500-l serial dilutions of the 10
11-cell/ml stock, from 10
11 to 10
1
cells/ml, were added to 0.2 g of feces, and each mixture was vortexed until
homogenous. Negative controls consisted of 0.2 g of feces with 500 l of sterile
phosphate-buffered saline. DNA was extracted from the feces by use of the
QIAamp DNA stool minikit (Qiagen GmbH, Hilden, Germany) according to the
manufacturer’s instructions. This extraction procedure was also subsequently
used with the test samples from the zoological collection.
Sequencing of PCR products. All ampliﬁed products from the primate feces
were sequenced with a commercially available cycle sequencing kit (ABI PRISM
dye terminator cycle sequencing ready reaction kit; Applied Biosystems Inc.)
according to the manufacturer’s instructions. The sequence data obtained were
aligned and compared with 16S ribosomal DNA (rDNA) sequences of B. aalborgi
513A
T (GenBank accession no. Z22781) and B. pilosicoli P43/6/78
T (GenBank
accession no. U23032) by using SeqEd, version 1.0.3 (Applied Biosystems Inc.;
1995).
Isolation. For isolation of B. aalborgi, fecal samples from the primates were
plated to TSA containing 10% (vol/vol) deﬁbrinated ovine blood, spectinomycin
(400 g/ml), colistin (25 g/ml), and polymyxin (5 g/ml) and cultured in an
atmosphere of 94% H2 and 6% CO2 at 37°C for 26 days. For isolation of
B. pilosicoli, the plates contained 5% ovine blood, spectinomycin (400 g/ml),
colistin (25 g/ml), and vancomycin (25 g/ml) and were incubated for up to 10
days. Spirochete growth on the B. aalborgi plates was subcultured to the same
plate type, as well as to the same plate type in which the polymyxin was replaced
with vancomycin (25 g/ml). Contamination was reduced on the latter plate type,
and after 21 days the spirochetes were subcultured from these plates to TSA
TABLE 1. Species and numbers of nonhuman primates sampled
Species Common name
No. of samples
Tested Positive in B. aalborgi PCR
a
Prosimians
Lemur catta Ring-tailed lemur 2 0
Eulemur fulvus albifrons White-fronted lemur 2 0
Varecia variegata Black and white ruffed lemur 2 0
Catarrhines
Hominidae
Pongo pygmaeus abelii Orangutan 5 0
Hylobatidae
Hylobates concolor leucogenys White-cheeked gibbon 1 0
Hylobates moloch Silvery gibbon 1 0
Cercopithecidae (Old World monkeys)
Saguinus oedipus Cotton-topped tamarin 2 0
Presbytis senex Western purple-faced langur 2 0
Cercopithecus aethiops Vervet 3 2
Macaca fuscata Japanese macaque 1 1
Colobus guereza Colobus monkey 2 0
Macaca nigra Crested macaque 1 0
Macaca tonkeana Tonkean macaque 2 2
Papio hamadryas Hamadryas baboon 1 1
Platyrrhines (New World monkeys)
Saguinus imperator Emperor tamarin 2 0
Aotus trivirgatus Owl monkey 1 0
Cebus capucinus White-fronted capuchin 1 0
Callithrix jacchus Common marmoset 2 0
Leontopithecus rosalia Golden lion tamarin 2 0
a No fecal samples positive for B. pilosicoli by PCR.
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picks were made from the plates and subjected to PCR, and the product se-
quences were compared with those obtained directly from the fecal samples.
Growth from the plates was also transferred into Kunkle’s medium, a prereduced
anaerobic Trypticase soy broth (BBL) containing 2% fetal calf serum and
0.002% ethanolic cholesterol (11).
API- ZYM. The enzymatic reactions of the isolates obtained were tested with
the commercial API- ZYM system (Analytab Products, Marcy-l’Etoile, France),
as previously described for B. aalborgi (7, 9). Bacteria were pelleted by centrif-
ugation from Kunkle’s broth, resuspended in sterile distilled water to 10
7 cells/
ml, and placed in the test cupules, and the strips were read after4ho fincubation
at 37°C. To test for indole production, 2 ml of broth culture (10
8 cells/ml) was
extracted with 1 ml of xylene and then 4 drops of Kova ´cs’ reagent were added.
Development of a red or purple color at the surface indicated a positive culture.
Growth of Brachyspira hyodysenteriae strain B78
T was used as a positive control.
Electron microscopy. For electron microscopy, the spirochetes were scraped
from the subculture plates and resuspended in distilled water. Drops of the
suspensions were placed on Formvar-coated reinforced grids and stained with
phosphotungstic acid (3%, pH 7.2). Grids were examined in a Philips CM100
Biotwin transmission electron microscope.
RESULTS
PCR detection limits. The lower limit of detection for the
B. aalborgi-speciﬁc PCR was between 2.5  10
4 and 2.5  10
5
cells per g of seeded human feces, equivalent to 2.5  10
2 to
2.4  10
3 cells per PCR. For the B. pilosicoli PCR, the detec-
tion level was between 2.5  10
5 and 2.5  10
6 cells per g of
human feces, or 2.5  10
3 to 2.5  10
4 cells per PCR.
PCR. When the PCRs were applied to DNA extracted from
the feces collected at the zoo, 6 of the 35 (17.1%) fecal samples
from the 19 species of primates examined were positive in the
B. aalborgi PCR. The positive samples came from 4 of 8 species
of Old World monkeys (comprising a total of 14 individuals)
(Table 1). None of the samples from other animal or bird
species were positive in this PCR, and none of the samples
from primates or other species were positive in the B. pilosicoli
PCR.
Sequence analysis. Results of the analysis of the sequences
over 433 bp of the 16S rDNA B. aalborgi PCR product for the
six positive reactions and comparisons with the corresponding
sequences of type strains of B. aalborgi and B. pilosicoli are
shown in Table 2. All detected products had from 96.7 to
97.8% sequence identity with B. aalborgi 513A
T and only 94.2
to 94.7% identity with B. pilosicoli P43/6/78
T. The sequences
from the three macaques were identical and were the most
closely related to that of the type strain from humans (97.8%
identity). Products from the two vervet monkeys were 99.8%
identical and had 98.5% sequence identity to the product from
the baboon.
Isolation and characterization. After 26 days of culture,
followed by subculture of initial growth for 21 days, isolates of
B. aalborgi were obtained from the two PCR-positive vervet
monkeys (Z12 and Z17). By phase-contrast microscopy, spiro-
chetes were also seen in the primary inoculum on the initial
isolation plates inoculated with feces from the Japanese ma-
caque (Z13) and one Tonkean macaque (Z23), but these could
not be isolated. Growth from the vervet monkeys appeared as
a thin haze on the plates, with moderate hemolysis around the
growth. The sequence of 16S rDNA PCR product generated
from these isolates was identical to those obtained directly
from the feces of these animals. In API-ZYM, the two isolates
had identical proﬁles, with the only activities being strong
-galactosidase activity and weak phosphohydrolase and alka-
line phosphatase activities. In Table 3 these activities are con-
trasted with those reported for human Swedish isolate W1 and
strain 513A
T (9). The only consistent differences from the two
human-derived strains were that the vervet isolates lacked the
reported weak esterase-lipase and acid phosphatase activities.
Under the electron microscope, both isolates had a morphol-
ogy similar to that previously described for human isolates of
B. aalborgi (7). The cells were sigmoidal with tapered ends,
w e r e2t o6m long and 0.2 m wide, and had four periplasmic
ﬂagella inserted at each cell end (Fig. 1).
DISCUSSION
The PCRs that were used for detection of intestinal spiro-
chetes had some limitations. For example, the detection limits
were established by using human feces, and these may be
different from the limits in feces from nonhuman primates or
other animal species. The thresholds for detection of both
spirochete species were quite high, and the failure to detect B.
pilosicoli DNA from feces collected at the zoo may have been
due to the poor detection limit of the B. pilosicoli PCR com-
pared to that of the B. aalborgi PCR. Nevertheless, the failure
to detect B. pilosicoli by PCR or by isolation in primates and
other species examined was consistent with the results of a
previous survey of this zoological collection (16). In that study,
feces from 204 animals, including primates, were subjected to
selective culture for B. pilosicoli, but only a single isolate was
obtained from a domestic pig.
TABLE 2. Percent similarities between the 16S rDNA PCR
product sequences obtained from the six positive samples
and B. aalborgi type strain 513A
T and comparisons




% Similarity over 433 bp for:
B. aalborgi 513A
T B. pilosicoli P43/6/78
T
Z13; Japanese macaque 97.8 94.2
Z18; Tonkean macaque 1 97.8 94.7
Z23; Tonkean macaque 2 97.8 94.7
Z28; Hamadryas baboon 96.9 94.7
Z12; vervet 1 96.9 94.7
Z17; vervet 2 96.7 94.7
B. aalborgi 513A
T 100 94.0
TABLE 3. Biochemical reactivity of the vervet monkey isolates






2 3 4 11 12 14
Vervet isolates 1 0 0 0 2 5
B. aalborgi 513A
T 1012 2 5
B. aalborgi W 1 0112 2 5
a Reactions in the API-ZYM system. Numerals indicate level of reaction: 0,
negative reaction; 1, weak positive reaction; 5, strong positive reaction.
b Enzyme numbers: 2, alkaline phosphatase; 3, esterase; 4, esterase-lipase; 11,
acid phosphatase; 12, naphthol-AS-BI-phosphohydrolase; 14, -galactosidase.
The other 13 enzymes in the API-ZYM panel were negative for all strains, as
were the indole reactions.
c Results for strain 513A
T and for Swedish strain W1 from humans are from
reference 9.
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PCRs demonstrated that all the spirochetes detected in
the primates were more closely related to B. aalborgi (96.7 to
97.8% identity) than to B. pilosicoli (94.2 to 94.7% identity).
Previously, a comparison of partial 16S rDNA sequences (from
a diagnostic PCR product) from the four available human
isolates of B. aalborgi showed that these have 99.5% identity
(8). Hence the spirochetes detected here apparently diverge
somewhat from typical human isolates of B. aalborgi. It would
not be appropriate to present a phylogenetic analysis of these
nonhuman primate isolates based on the small amount of 16S
rRNA gene sequence currently available. It is clear that the
nonhuman primate isolates have in vitro growth characteris-
tics, morphologies, and biochemical reactivities similar to
those of the human isolates and are best considered B. aal-
borgi. Further work to clarify the exact relationships between
the human and nonhuman primate isolates is required.
This is the second study that has used PCR to detect B.
aalborgi in nonhuman primates, and it is the ﬁrst to achieve this
by using DNA extracted directly from feces. In the previous
PCR study, B. aalborgi (and B. pilosicoli) DNA was detected in
colonic biopsy specimens from colony-raised primates with
histological evidence of IS (4). The identiﬁcation of B. aalborgi
in animals in a public zoological collection in the present study
raises the question of the origin of these organisms and their
potential for zoonotic spread. A survey of feces from a selec-
tion of other animals and birds in the collection failed to
identify any other reservoirs of infection. The apparent sensi-
tivity of detection of the B. aalborgi PCR was not particularly
good, and the possibility that additional primates or other
species could have been colonized at an undetectable level
cannot be excluded. All the primates were captive bred, and in
the preceding 17 years the only primate acquisitions were two
Tonkean macaques, obtained from the Rotterdam zoo. While
two Tonkean macaques were positive for B. aalborgi in this
study, it was not recorded whether these were the same indi-
viduals that were introduced. There was no direct contact be-
tween the various primate species in the different enclosures,
and the sequence variation among the PCR products indicated
that there were several strains of the organism present in
different primate species. Overall, these results indicate that
B. aalborgi can persist among groups of individuals for pro-
longed periods (decades), suggesting that they are part of the
autochthonous microﬂora in these animals. Nevertheless, as in
humans, they may perhaps act as opportunistic pathogens un-
der certain circumstances (19). Although none of the animals
showed evidence of disease, the presence of histological IS
and/or colitis was not investigated. Even if these strains of
B. aalborgi have a commensal relationship with nonhuman pri-
mates, it is possible that they could be transmitted to humans
and cause disease. This zoonotic potential requires further study.
The approximate 50% colonization rate in Old World mon-
keys found here was in contrast to the failure to detect B.
aalborgi in prosimians (three species, six individuals) or platyr-
rhines (New World monkeys; six species, eight individuals).
Interestingly, there have been no previous reports of intestinal
spirochetes colonizing prosimians or New World monkeys.
This could either be because too few animals have been exam-
ined or because they are not naturally colonized. In contrast,
Old World monkeys commonly have been shown to have his-
FIG. 1. Transmission electron microscope appearance of negatively stained B. aalborgi isolate Z12 from a vervet monkey.
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22), baboons (17), crab-eating monkeys (4), and vervets (2).
These results could be interpreted as suggesting that B. aal-
borgi has coevolved with the catarrhines (the group including
the Old World monkeys, gibbons, great apes, and humans),
following an initial colonization after their separation (geo-
graphic and evolutionary) from the New World monkeys some
35 to 37 million years ago. Colonization of human beings with
B. aalborgi has been recorded in many parts of the world (12),
presumably reﬂecting later human migration from the Old
World. Although in this study colonization was not detected in
other members of the catarrhines, including ﬁve orangutans
(family Pongidae) and two gibbons from different species (fam-
ily Hylobatidae), these captive individuals may simply not have
been exposed to the organism. It would be of considerable
interest to look for the presence of B. aalborgi in other captive
and wild members of the last two families, as well as in New
World monkeys. The catarrhines are all omnivorous and mono-
gastric, and the similarity of their gastrointestinal systems, per-
haps including similar colonic epithelial receptors and intesti-
nal microenvironments, might facilitate colonization by
B. aalborgi.
In view of the present successful isolation of B. aalborgi from
feces (the ﬁrst time that this has been achieved for this spiro-
chete species), it may be possible to obtain sufﬁcient isolates
for a much more comprehensive molecular analysis of the
species, such that the comparative phylogeny of B. aalborgi and
members of the catarrhines can be studied. The variation iden-
tiﬁed here in the 16S rDNA PCR products from the different
primate species encourages this hypothesis. The availability of
isolates will also allow future studies on the pathogenicity of
the organisms, provided that a suitable animal model can be
developed.
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